SYNLOGIC, INC. Increase (Decrease) in Deferred Revenue
SYNLOGIC, INC. (SYBX) reported Increase (Decrease) in Deferred Revenue of -$354.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-05-15
- SYNLOGIC, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$354.00K.
- SYNLOGIC, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$111.00K.
- SYNLOGIC, INC. increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was -$111.00K.
- SYNLOGIC, INC. increase (decrease) in deferred revenue for the quarter ending 2016-12-31 was -$111.00K.
- SYNLOGIC, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$444.00K.
- SYNLOGIC, INC. increase (decrease) in deferred revenue for fiscal 2016 was -$444.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$354.00K 10-Q · filed 2018-05-15 | -$465.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2017-12-31 | -$111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$444.00K 10-K · filed 2018-03-20 | ||
| 2017-09-30 | -$333.00K 10-Q · filed 2017-11-13 | |||
| 2017-03-31 | -$111.00K 10-Q · filed 2018-05-15 | -$222.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | -$111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$444.00K 10-K · filed 2018-03-20 | ||
| 2016-09-30 | -$333.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |